Financials PetIQ, Inc.

Equities

PETQ

US71639T1060

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
20.76 USD +0.92% Intraday chart for PetIQ, Inc. +4.85% +5.11%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 586.7 972.3 661.7 267.1 576.5 612.8 - -
Enterprise Value (EV) 1 822.5 972.3 661.7 267.1 576.5 612.8 612.8 612.8
P/E ratio -49.1 x -12.2 x -39.8 x - - - - -
Yield - - - - - - - -
Capitalization / Revenue 0.83 x 1.25 x 0.71 x 0.29 x 0.52 x 0.53 x 0.5 x 0.47 x
EV / Revenue 0.83 x 1.25 x 0.71 x 0.29 x 0.52 x 0.53 x 0.5 x 0.47 x
EV / EBITDA 9.67 x 14.3 x 7.12 x 3.44 x 5.51 x 5.31 x 4.93 x 4.35 x
EV / FCF 55.6 x - - - 10.9 x 8.63 x 8.28 x 7.76 x
FCF Yield 1.8% - - - 9.15% 11.6% 12.1% 12.9%
Price to Book - - 2.67 x - - - - -
Nbr of stocks (in thousands) 23,420 25,286 29,135 28,973 29,188 29,520 - -
Reference price 2 25.05 38.45 22.71 9.220 19.75 20.76 20.76 20.76
Announcement Date 3/10/20 2/25/21 3/1/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 709.4 780.1 932.5 921.5 1,102 1,159 1,223 1,314
EBITDA 1 60.68 67.79 92.89 77.69 104.7 115.5 124.4 140.8
EBIT 1 45.54 42.9 56.19 45.09 60.14 78.56 88.73 109
Operating Margin 6.42% 5.5% 6.03% 4.89% 5.46% 6.78% 7.25% 8.3%
Earnings before Tax (EBT) 1 -17.61 -28.81 -12.51 - 2.366 36.86 44.63 -
Net income 1 -11.45 -77.47 -15.97 - 2.131 37.61 46.86 -
Net margin -1.61% -9.93% -1.71% - 0.19% 3.24% 3.83% -
EPS -0.5100 -3.150 -0.5700 - - - - -
Free Cash Flow 1 10.56 - - - 52.74 71 74 79
FCF margin 1.49% - - - 4.79% 6.12% 6.05% 6.01%
FCF Conversion (EBITDA) 17.4% - - - 50.37% 61.47% 59.49% 56.11%
FCF Conversion (Net income) - - - - 2,474.99% 188.78% 157.9% -
Dividend per Share - - - - - - - -
Announcement Date 3/10/20 2/25/21 3/1/22 2/28/23 2/28/24 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 196.6 275.7 252 209.7 184.1 290.5 314.5 277 219.9 308.4 330.1 288.7 232.1 323.5 348.2
EBITDA 1 15.31 31.6 27.58 19.21 12.88 30.72 32.87 29.28 12 35.26 34.87 29.09 16.25 38.53 36.06
EBIT 1 5.707 23.39 19.59 11.75 4.655 22.94 22.23 13.88 1.255 27.57 25.54 20.12 6.56 28.82 26.34
Operating Margin 2.9% 8.48% 7.77% 5.6% 2.53% 7.9% 7.07% 5.01% 0.57% 8.94% 7.74% 6.97% 2.83% 8.91% 7.56%
Earnings before Tax (EBT) 1 - 3.281 - - - - - 0.739 -18.35 15.35 15.52 10.62 -4.628 19.26 15.4
Net income 1 -14.12 3.131 - - - - - 0.451 -17.49 14.91 16.3 11.15 -4.859 20.22 16.17
Net margin -7.18% 1.14% - - - - - 0.16% -7.95% 4.83% 4.94% 3.86% -2.09% 6.25% 4.64%
EPS -0.4900 0.1100 - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/1/22 5/4/22 8/9/22 11/9/22 2/28/23 5/9/23 8/8/23 11/7/23 2/28/24 5/8/24 - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 236 - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 3.888 x - - - - - - -
Free Cash Flow 1 10.6 - - - 52.7 71 74 79
ROE (net income / shareholders' equity) - - -6.75% - - - - -
ROA (Net income/ Total Assets) - - -2.01% - - - - -
Assets 1 - - 795.6 - - - - -
Book Value Per Share - - 8.520 - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 10.3 22.4 31.3 12 9.15 9 12 13
Capex / Sales 1.45% 2.87% 3.35% 1.3% 0.83% 0.78% 0.98% 0.99%
Announcement Date 3/10/20 2/25/21 3/1/22 2/28/23 2/28/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
20.76 USD
Average target price
29.33 USD
Spread / Average Target
+41.30%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PETQ Stock
  4. Financials PetIQ, Inc.